CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
6.58
-0.06 (-0.90%)
At close: Jan 22, 2026, 4:00 PM EST
6.61
+0.03 (0.46%)
After-hours: Jan 22, 2026, 4:20 PM EST
CervoMed Employees
CervoMed had 15 employees as of December 31, 2024. The number of employees increased by 7 or 87.50% compared to the previous year.
Employees
15
Change (1Y)
7
Growth (1Y)
87.50%
Revenue / Employee
$410,652
Profits / Employee
-$1,705,666
Market Cap
60.61M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 15 | 7 | 87.50% |
| Dec 31, 2023 | 8 | 4 | 100.00% |
| Dec 31, 2022 | 4 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| TScan Therapeutics | 195 |
| Metagenomi Therapeutics | 124 |
| Acrivon Therapeutics | 78 |
| ImmuCell | 75 |
| PMV Pharmaceuticals | 47 |
| MiNK Therapeutics | 23 |
| Tevogen Bio Holdings | 18 |
| Radiopharm Theranostics | 14 |
CRVO News
- 7 weeks ago - CervoMed Announces Late-Breaking Data at the 18th CTAD Conference Demonstrating Neflamapimod Significantly Slows Clinical Progression in Dementia with Lewy Bodies - GlobeNewsWire
- 7 weeks ago - CervoMed Presents New Plasma Biomarker Data That Indicates Neflamapimod Broadly Improves Neuroinflammation and Neurodegeneration in Dementia with Lewy Bodies (DLB) - GlobeNewsWire
- 2 months ago - CervoMed to Share New Data on Neflamapimod as a Treatment for Dementia with Lewy Bodies at the 18th Clinical Trials on Alzheimer's Disease (CTAD) Conference - GlobeNewsWire
- 3 months ago - CervoMed to Present at the Emerging Growth Conference - GlobeNewsWire
- 3 months ago - CervoMed Drug Cut Dementia Progression Risk By 75% In Trial - Benzinga
- 3 months ago - CervoMed Announces New Data from Phase 2b Trial Demonstrating Neflamapimod's Potential as a Treatment for Dementia with Lewy Bodies - GlobeNewsWire
- 4 months ago - CervoMed to Participate in the 4th Annual ROTH Healthcare Opportunities Conference - GlobeNewsWire
- 4 months ago - CervoMed Highlights Neflamapimod's Potential Benefits in Session on Dementia with Lewy Bodies at the 150th Annual American Neurology Association Conference - GlobeNewsWire